Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm

authors:

avatar Omid Moradi 1 , * , avatar Seyed pouzhia Shojaei 2 , avatar Mehran Kouchek ORCID 2 , avatar MirMohammad Miri 2 , avatar Sara Salarian ORCID 2 , avatar Mohammad Sistanizad ORCID 1

Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Critical Care Medicine Ward, Anesthesiology Department, Imam Hossein (A.S.) Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Journal of Cellular & Molecular Anesthesia: Vol.5, issue 3; e150187
published online: July 23, 2020
article type: Letter to the Editor
DOI: https://doi.org/10.22037/jcma.v5i3.30630

how to cite: Moradi O, Shojaei S P, Kouchek M, Miri M, Salarian S, et al. Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm. J Cell Mol Anesth. 2020;5(3):e150187. https://doi.org/10.22037/jcma.v5i3.30630.

Abstract

References

  • 1.

    References are in the PDF file of the article.